TRPA1 and neoplasm: Even some approved drugs or novel drugs in clinical trials are available, which modulate some potentially tumor-relevant TRP channels, e.g., GRC 17536 (TRPA1) [86], XEN-D0501 (TRPV1) [80], SB705498 (TRPV1) [87].